The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Kane Biotech Inc closed at $0.04.

Although unchanged over the last five days, shares are down 58.82% for the last year to date. This security has underperformed the S&P TSX by 71.19% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated December 19 4:41 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-719.94%

Kane Biotech Inc has a net profit margin of -719.94%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0------
Total cost of revenue0------
Total operating expense0000
Selling / general / administrative0000
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income0000
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets0000
Other--------
Income before tax0-100
Income after tax0-100
Income tax, total0000
Net income0-100
Total adjustments to net income--------
Net income before extra. items0-100
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0-100
Inc. avail. to common incl. extra. items0-100
Diluted net income0-100
Dilution adjustment--------
Diluted weighted average shares82818179
Diluted EPS excluding extraordinary itemsvalue per share0.00-0.010.000.00
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.00-0.010.000.00